Effects of Dietary Yeast β-1,3/1,6-D-Glucan on Immunomodulation in RAW 264.7 Cells and Methotrexate-Treated Rat Models
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011020 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Joohee Son und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Herbal Pharmacology, College of Korean Medicine, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam-si 13120, Republic of Kor…. Hauptthemen laut MEDLINE: Methotrexate, beta-Glucans, Immunomodulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FINE BS Co., Ltd., Leiber GmbH, Korea government (MSIT).
Abstract (Originalsprache)
A new subclass of nutraceuticals, called immunoceuticals, is dedicated to immunological regulation. Although yeast-derived β-1,3/1,6-D-glucan shows promise as an immunoceutical candidate, further studies are needed to define its precise immune-enhancing processes and to standardize its use. Following methotrexate (MTX)-induced immunosuppression in rats, we evaluated the immunomodulatory efficacy of a highly pure and standardized β-1,3/1,6-D-glucan sample (YBG) in RAW 264.7 macrophages. In in vitro and in vivo models, YBG demonstrated remarkable immunomodulatory effects, such as repair of immune organ damage, elevation of blood cytokine levels, and enhanced phagocytosis and nitric oxide production in RAW 264.7 cells. These results are consistent with the established immunostimulatory properties of β-glucan. It is noteworthy that this research indicates the potential of YBG as an immunomodulatory nutraceutical, as it is among the first to demonstrate immunological augmentation in an immunosuppression setting produced by MTX. Based on these observations, further investigation of YBG is warranted, particularly given its potential to emerge as a combination immunoceutical to mitigate immunosuppression and reduce the risk of infection in rheumatoid arthritis (RA) patients receiving long-term MTX therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Herbal Pharmacology, College of Korean Medicine, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam-si 13120, Republic of Korea.
- Department of Nutraceutical Ingredients Research, FINE BS Co., Ltd., 76 Yeonmujang-gil, Seongdong-gu, Seoul 04784, Republic of Korea.
- Department of Product Management Nutraceuticals & Biotechnology, Leiber GmbH, Franz-Leiber-Straße 1, 49565 Bramsche, Germany.
- Research Institute, Medicro Co., Ltd., Anyang 14067, Republic of Korea.
- Naturalis Inc., 6, Daewangpangyo-ro, Bundang-gu, Seongnam-si 13549, Republic of Korea.
ORCID-Profile: Yeseul Hwang, Eun-Mi Hong, Hee-Geun Jo, Donghun Lee
Förderung
- FINE BS Co., Ltd.
- Leiber GmbH
- Korea government (MSIT)
- Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Son, J., Hwang, Y., Hong, E. M., Schulenberg, M., Chai, H., Jo, H. G., & Lee, D. (2024). Effects of Dietary Yeast β-1,3/1,6-D-Glucan on Immunomodulation in RAW 264.7 Cells and Methotrexate-Treated Rat Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011020
Vancouver
Son J, Hwang Y, Hong EM, Schulenberg M, Chai H, Jo HG, et al. Effects of Dietary Yeast β-1,3/1,6-D-Glucan on Immunomodulation in RAW 264.7 Cells and Methotrexate-Treated Rat Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011020
BibTeX
@article{Son2024,
author = {Son, Joohee and Hwang, Yeseul and Hong, Eun-Mi and Schulenberg, Marion and Chai, Hyungyung and Jo, Hee-Geun and Lee, Donghun},
title = {Effects of Dietary Yeast β-1,3/1,6-D-Glucan on Immunomodulation in RAW 264.7 Cells and Methotrexate-Treated Rat Models},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011020}
}
EUVIMED